{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:14:28Z","timestamp":1781644468452,"version":"3.54.5"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T00:00:00Z","timestamp":1563321600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T00:00:00Z","timestamp":1563321600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Perinatol"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1038\/s41372-019-0437-3","type":"journal-article","created":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T08:03:52Z","timestamp":1563350632000},"page":"1535-1545","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Comparative effectiveness of opioid replacement agents for neonatal opioid withdrawal syndrome: a systematic review and meta-analysis"],"prefix":"10.1038","volume":"39","author":[{"given":"Jennifer J.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerri","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Eisler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena S.","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,17]]},"reference":[{"key":"437_CR1","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1056\/NEJMsa1500439","volume":"372","author":"VN Tolia","year":"2015","unstructured":"Tolia VN, Patrick SW, Bennett MM, Murthy K, Sousa J, Smith PB, et al. Increasing incidence of the neonatal abstinence syndrome in U.S. neonatal ICUs. N Engl J Med. 2015;372:2118\u201326.","journal-title":"N Engl J Med"},{"key":"437_CR2","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/jp.2015.63","volume":"35","author":"SW Patrick","year":"2015","unstructured":"Patrick SW, Davis MM, Lehman CU, Cooper WO. Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012. J Perinatol: Off J Calif Perinat Assoc. 2015;35:667.","journal-title":"J Perinatol: Off J Calif Perinat Assoc"},{"key":"437_CR3","doi-asserted-by":"publisher","first-page":"e547","DOI":"10.1542\/peds.2013-3524","volume":"134","author":"P Kocherlakota","year":"2014","unstructured":"Kocherlakota P. Neonatal abstinence syndrome. Pediatrics. 2014;134:e547\u201361.","journal-title":"Pediatrics"},{"key":"437_CR4","doi-asserted-by":"crossref","unstructured":"Osborn DA, Jeffery HE. Cole MJ, Opiate treatment for opiate withdrawal in newborn infants. Cochrane Datab Syst Rev. 2010;10:Cd002059.","DOI":"10.1002\/14651858.CD002059.pub3"},{"key":"437_CR5","doi-asserted-by":"crossref","unstructured":"Osborn DA, Jeffery HE, Cole MJ. Sedatives for opiate withdrawal in newborn infants. Cochrane Datab Syst Rev. 2010;10:Cd002053.","DOI":"10.1002\/14651858.CD002053.pub3"},{"key":"437_CR6","doi-asserted-by":"publisher","first-page":"e540","DOI":"10.1542\/peds.2011-3212","volume":"129","author":"ML Hudak","year":"2012","unstructured":"Hudak ML, Tan RC. Neonatal drug withdrawal. Pediatrics. 2012;129:e540\u201360.","journal-title":"Pediatrics"},{"key":"437_CR7","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.acap.2016.10.003","volume":"17","author":"DL Bogen","year":"2017","unstructured":"Bogen DL, Whalen BL, Kair LR, Vining M, King BA. Wide variation found in care of opioid-exposed newborns. Acad Pedia. 2017;17:374\u201380.","journal-title":"Acad Pedia"},{"key":"437_CR8","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1177\/0009922807300699","volume":"46","author":"MT Crocetti","year":"2007","unstructured":"Crocetti MT, Amin DD, Jansson LM. Variability in the evaluation and management of opiate-exposed newborns in Maryland. Clin Pediatr. 2007;46:632\u20135.","journal-title":"Clin Pediatr"},{"key":"437_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/sj.jp.7211427","volume":"26","author":"S Sarkar","year":"2006","unstructured":"Sarkar S, Donn SM. Management of neonatal abstinence syndrome in neonatal intensive care units: a national survey. J Perinatol: Off J Calif Perinat Assoc. 2006;26:15\u20137.","journal-title":"J Perinatol: Off J Calif Perinat Assoc"},{"key":"437_CR10","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1542\/hpeds.2012-0079","volume":"3","author":"A Mehta","year":"2013","unstructured":"Mehta A, Forbes KD, Kuppala VS. Neonatal abstinence syndrome management from prenatal counseling to postdischarge follow-up care: results of a national survey. Hosp Pediatr. 2013;3:317\u201323.","journal-title":"Hosp Pediatr"},{"issue":"3","key":"437_CR11","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1001\/jamapediatrics.2018.5044","volume":"173","author":"Timothy Disher","year":"2019","unstructured":"Disher T, Gullickson C, Singh B, Cameron C, Boulos L, Beaubien L, et al. Pharmacological treatments for neonatal abstinence syndrome: a systematic review and network meta-analysis. JAMA Pediatr. 2019;173:234\u201343.","journal-title":"JAMA Pediatrics"},{"key":"437_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Method. 2014;14:135.","journal-title":"BMC Med Res Method"},{"key":"437_CR13","unstructured":"Sutter MB. Morphine versus methadone for opiate exposed infants with neonatal abstinence syndrome. NLM identifier: NCT02851303 https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02851303?type=Intr&cond=Neonatal+Abstinence+Syndrome&rank=14 ."},{"key":"437_CR14","unstructured":"Martin G. Comparison of buprenorphine to morphine in treatment of neonatal abstinence Syndrome (NAS). NLM identifier: NCT01708707 https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01708707?type=Intr&cond=Neonatal+Abstinence+Syndrome&rank=11 ."},{"key":"437_CR15","unstructured":"Kushnir A. Treatment of neonatal abstinence syndrome with clonidine versus morphine as primary therapy. NLM identifier: NCT03092011 https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03092011?type=Intr&cond=Neonatal+Abstinence+Syndrome&draw=2&rank=1 ."},{"key":"437_CR16","unstructured":"Gauda E. Sublingual buprenorphine treatment for neonatal abstinence syndrome - Pilot Study. NLM identifier: NCT02249026 https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02249026?type=Intr&cond=Neonatal+Abstinence+Syndrome&rank=25 ."},{"key":"437_CR17","unstructured":"Davis JM, Lester B. Improving outcomes in neonatal abstinence syndrome. NLM identifier: NCT01958476 https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01958476type=Intr&cond=Neonatal+Abstinence+Syndrome&rank=6 ."},{"key":"437_CR18","unstructured":"Brooks S. Methadone Demonstration Project. NLM identifier: NCT03134703 https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03134703?type=Intr&cond=Neonatal+Abstinence+Syndrome&rank=20 ."},{"key":"437_CR19","unstructured":"Bada HS. Non-opiate treatment after prenatal opiate exposure to prevent postnatal injury to the young brain (No-POPPY). NLM identifier: NCT03396588 https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03396588?type=Intr&cond=Neonatal+Abstinence+Syndrome&rank=18 ."},{"key":"437_CR20","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1055\/s-0037-1608634","volume":"35","author":"ES Hall","year":"2018","unstructured":"Hall ES, Rice WR, Folger AT, Wexelblatt SL. Comparison of neonatal abstinence syndrome treatment with sublingual buprenorphine versus conventional opioids. Am J Perinatol. 2018;35:405\u201312.","journal-title":"Am J Perinatol"},{"key":"437_CR21","doi-asserted-by":"crossref","first-page":"2333794x1772112","DOI":"10.1177\/2333794X17721128","volume":"4","author":"S Burke","year":"2017","unstructured":"Burke S, Beckwith AM. Morphine versus methadone treatment for neonatal withdrawal and impact on early infant development. Glob Pediatr health. 2017;4:2333794x17721128.","journal-title":"Glob Pediatr health"},{"key":"437_CR22","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/jp.2014.194","volume":"35","author":"MS Brown","year":"2015","unstructured":"Brown MS, Hayes MJ, Thornton LM. Methadone versus morphine for treatment of neonatal abstinence syndrome: a prospective randomized clinical trial. J Perinatol: Off J Calif Perinat Assoc. 2015;35:278\u201383.","journal-title":"J Perinatol: Off J Calif Perinat Assoc"},{"issue":"23Suppl 3","key":"437_CR23","doi-asserted-by":"publisher","first-page":"S162","DOI":"10.2146\/sp150025","volume":"72","author":"ME Young","year":"2015","unstructured":"Young ME, Hager SJ, Spurlock D Jr. Retrospective chart review comparing morphine and methadone in neonates treated for neonatal abstinence syndrome. Am J Health-Syst Pharm: AJHP: Off J Am Soc Health-Syst Pharm. 2015;72(23Suppl 3):S162\u20137.","journal-title":"Am J Health-Syst Pharm: AJHP: Off J Am Soc Health-Syst Pharm"},{"key":"437_CR24","doi-asserted-by":"publisher","first-page":"e527","DOI":"10.1542\/peds.2013-4036","volume":"134","author":"ES Hall","year":"2014","unstructured":"Hall ES, Wexelblatt SL, Crowley M, Grow JL, Jasin LR, Klebanoff MA, et al. A multicenter cohort study of treatments and hospital outcomes in neonatal abstinence syndrome. Pediatrics. 2014;134:e527\u201334.","journal-title":"Pediatrics"},{"key":"437_CR25","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/jp.2014.114","volume":"34","author":"SW Patrick","year":"2014","unstructured":"Patrick SW, Kaplan HC, Passarella M, Davis MM, Lorch SA. Variation in treatment of neonatal abstinence syndrome in US children\u2019s hospitals, 2004\u20132011. J Perinatol: Off J Calif Perinat Assoc. 2014;34:867\u201372.","journal-title":"J Perinatol: Off J Calif Perinat Assoc"},{"key":"437_CR26","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.adnc.2005.06.003","volume":"5","author":"S Lainwala","year":"2005","unstructured":"Lainwala S, Brown ER, Weinschenk NP, Blackwell MT, Hagadorn JI. A retrospective study of length of hospital stay in infants treated for neonatal abstinence syndrome with methadone versus oral morphine preparations. Adv Neonatal Care: Off J Natl Assoc Neonatal Nurses. 2005;5:265\u201372.","journal-title":"Adv Neonatal Care: Off J Natl Assoc Neonatal Nurses"},{"key":"437_CR27","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1056\/NEJMoa1614835","volume":"376","author":"WK Kraft","year":"2017","unstructured":"Kraft WK, Adeniyi-Jones SC, Chervoneva I, Greenspan JS, Abatemarco D, Kaltenbach K, et al. Buprenorphine for the treatment of the neonatal abstinence syndrome. New Engl J Med. 2017;376:2341\u20138.","journal-title":"New Engl J Med"},{"key":"437_CR28","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/j.1360-0443.2010.03170.x","volume":"106","author":"WK Kraft","year":"2011","unstructured":"Kraft WK, Dysart K, Greenspan JS, Gibson E, Kaltenbach K, Ehrlich ME. Revised dose schema of sublingual buprenorphine in the treatment of the neonatal opioid abstinence syndrome. Addiction. 2011;106:574\u201380.","journal-title":"Addiction"},{"key":"437_CR29","doi-asserted-by":"publisher","first-page":"e601","DOI":"10.1542\/peds.2008-0571","volume":"122","author":"WK Kraft","year":"2008","unstructured":"Kraft WK, Gibson E, Dysart K, Damle VS, Larusso JL, Greenspan JS, et al. Sublingual buprenorphine for treatment of neonatal abstinence syndrome: a randomized trial. Pediatrics. 2008;122:e601\u20137.","journal-title":"Pediatrics"},{"key":"437_CR30","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jpeds.2015.11.039","volume":"170","author":"ES Hall","year":"2016","unstructured":"Hall ES, Isemann BT, Wexelblatt SL, Meinzen-Derr J, Wiles JR, Harvey S, et al. A cohort comparison of buprenorphine versus methadone treatment for neonatal abstinence syndrome. J Pediatr. 2016;170:39\u201344.e1.","journal-title":"J Pediatr"},{"key":"437_CR31","doi-asserted-by":"publisher","first-page":"e383","DOI":"10.1542\/peds.2014-2377","volume":"135","author":"HS Bada","year":"2015","unstructured":"Bada HS, Sithisarn T, Gibson J, Garlitz K, Caldwell R, Capilouto G, et al. Morphine versus clonidine for neonatal abstinence syndrome. Pediatrics. 2015;135:e383\u201391.","journal-title":"Pediatrics"},{"key":"437_CR32","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1651-2227.2009.01547.x","volume":"99","author":"A Esmaeili","year":"2010","unstructured":"Esmaeili A, Keinhorst AK, Schuster T, Beske F, Schlosser R, Bastanier C. Treatment of neonatal abstinence syndrome with clonidine and chloral hydrate. Acta Paediatr. 2010;99:209\u201314.","journal-title":"Acta Paediatr"},{"key":"437_CR33","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3389\/fped.2017.00216","volume":"5","author":"LA Devlin","year":"2017","unstructured":"Devlin LA, Lau T, Radmacher PG. Decreasing total medication exposure and length of stay while completing withdrawal for neonatal abstinence syndrome during the neonatal hospital stay. Front Pedia. 2017;5:216.","journal-title":"Front Pedia"},{"key":"437_CR34","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/jp.2013.95","volume":"33","author":"B Surran","year":"2013","unstructured":"Surran B, Visintainer P, Chamberlain S, Kopcza K, Shah B, Singh R. Efficacy of clonidine versus phenobarbital in reducing neonatal morphine sulfate therapy days for neonatal abstinence syndrome. A prospective randomized clinical trial. J Perinatol: Off J Calif Perinat Assoc. 2013;33:954\u20139.","journal-title":"J Perinatol: Off J Calif Perinat Assoc"},{"key":"437_CR35","doi-asserted-by":"publisher","first-page":"F73","DOI":"10.1136\/adc.2003.046276","volume":"90","author":"MG Coyle","year":"2005","unstructured":"Coyle MG, Ferguson A, Lagasse L, Liu J, Lester B. Neurobehavioral effects of treatment for opiate withdrawal. Arch Dis Child Fetal neonatal Ed. 2005;90:F73\u20134.","journal-title":"Arch Dis Child Fetal neonatal Ed"},{"key":"437_CR36","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1067\/mpd.2002.123099","volume":"140","author":"MG Coyle","year":"2002","unstructured":"Coyle MG, Ferguson A, Lagasse L, Oh W, Lester B. Diluted tincture of opium (DTO) and phenobarbital versus DTO alone for neonatal opiate withdrawal in term infants. J Pediatr. 2002;140:561\u20134.","journal-title":"J Pediatr"},{"key":"437_CR37","doi-asserted-by":"publisher","first-page":"e849","DOI":"10.1542\/peds.2008-0978","volume":"123","author":"AG Agthe","year":"2009","unstructured":"Agthe AG, Kim GR, Mathias KB, Hendrix CW, Chavez-Valdez R, Jansson L, et al. Clonidine as an adjunct therapy to opioids for neonatal abstinence syndrome: a randomized, controlled trial. Pediatrics. 2009;123:e849\u201356.","journal-title":"Pediatrics"},{"key":"437_CR38","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1001\/jamapediatrics.2018.1307","volume":"172","author":"JM Davis","year":"2018","unstructured":"Davis JM, Shenberger J, Terrin N, Breeze JL, Hudak M, Wachman EM, et al. Comparison of safety and efficacy of methadone vs morphine for treatment of neonatal abstinence syndrome: a randomized clinical trial. JAMA Pedia. 2018;172:741\u20138.","journal-title":"JAMA Pedia"},{"key":"437_CR39","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jpeds.2018.07.061","volume":"203","author":"VN Tolia","year":"2018","unstructured":"Tolia VN, Murthy K, Bennett MM, Greenberg RG, Benjamin DK, Smith PB, et al. Morphine vs methadone treatment for infants with neonatal abstinence syndrome. J Pediatr. 2018;203:185\u20139.","journal-title":"J Pediatr"},{"key":"437_CR40","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1056\/NEJMoa1005359","volume":"363","author":"HE Jones","year":"2010","unstructured":"Jones HE, Kaltenbach K, Heil SH, Stine SM, Coyle MG, Arria AM, et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med. 2010;363:2320\u201331.","journal-title":"N Engl J Med"},{"key":"437_CR41","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1053\/j.semperi.2015.12.007","volume":"40","author":"WK Kraft","year":"2016","unstructured":"Kraft WK, Stover MW, Davis JM. Neonatal abstinence syndrome: pharmacologic strategies for the mother and infant. Semin Perinatol. 2016;40:203\u201312.","journal-title":"Semin Perinatol"},{"key":"437_CR42","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1093\/bja\/aeh042","volume":"92","author":"NJ Boumeester","year":"2004","unstructured":"Boumeester NJ, AB, Tibboel D, et al. Developmental pharmacokinetics of morphine and its metabolites in neonates, infants, ad young children. Br J Anaesth. 2004;92:208\u201317.","journal-title":"Br J Anaesth"},{"key":"437_CR43","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/cpt.930","volume":"103","author":"WK Kraft","year":"2018","unstructured":"Kraft WK. Buprenorphine in neonatal abstinence syndrome. Clin Pharmacol Ther. 2018;103:112\u20139.","journal-title":"Clin Pharmacol Ther"},{"key":"437_CR44","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1177\/0883073808321056","volume":"24","author":"HK Blume","year":"2009","unstructured":"Blume HK, Garrison MM, Christakis DA. Neonatal seizures: treatment and treatment variability in 31 United States pediatric hospitals. J Child Neurol. 2009;24:148\u201354.","journal-title":"J Child Neurol"},{"issue":"2 Suppl","key":"437_CR45","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.36076\/ppj.2008\/11\/S133","volume":"11","author":"AM Trescot","year":"2008","unstructured":"Trescot AM, Datta S, Lee M, Hansen H. Opioid pharmacology. Pain Physician. 2008;11(2 Suppl):S133\u201353.","journal-title":"Pain Physician"},{"key":"437_CR46","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1111\/add.13842","volume":"112","author":"TE Corr","year":"2017","unstructured":"Corr TE, Hollenbeak CS. The economic burden of neonatal abstinence syndrome in the United States. Addiction. 2017;112:1590\u20139.","journal-title":"Addiction"},{"key":"437_CR47","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1001\/jamapediatrics.2017.5195","volume":"172","author":"KDL MacMillan","year":"2018","unstructured":"MacMillan KDL, Rendon CP, Verma K, Riblet N, Washer DB, Volpe Holmes A. Association of rooming-in with outcomes for neonatal abstinence syndrome: a systematic review and meta-analysis. JAMA Pedia. 2018;172:345\u201351.","journal-title":"JAMA Pedia"}],"container-title":["Journal of Perinatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41372-019-0437-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41372-019-0437-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41372-019-0437-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,21]],"date-time":"2024-07-21T01:57:23Z","timestamp":1721527043000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41372-019-0437-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,17]]},"references-count":47,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["437"],"URL":"https:\/\/doi.org\/10.1038\/s41372-019-0437-3","relation":{},"ISSN":["0743-8346","1476-5543"],"issn-type":[{"value":"0743-8346","type":"print"},{"value":"1476-5543","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,17]]},"assertion":[{"value":"7 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}